The bill mandates that the Alabama Medicaid Agency provide coverage for specific noninvasive colorectal cancer screening tests that receive a grade A or B from the United States Preventive Services Task Force. The covered tests include the guaiac fecal occult blood test (gFOBT), the fecal immunochemical test (FIT), and the multi-target stool DNA test (sDNA-FIT). Additionally, the bill requires that a colonoscopy be covered if it is performed following a positive result from one of these screening tests.

This new provision will be in effect for two years from the date the act becomes effective, which is set for October 1, 2025. After this period, the section will be repealed. The bill reflects a commitment to improving colorectal cancer screening access for Medicaid recipients in Alabama, aligning with national preventive health recommendations.